In patients suffering from proliferative lupus glomerulonephritis, BG9588, a humanized anti-human CD40L antibody, while showing beneficial immunomodulatory action, caused severe thromboembolic events (i.e., two myocardial infarctions) [103]. This evidence concerns the gene CD40LG and myocardial infarction.